Upgrade to SI Premium - Free Trial

TD Cowen on Gilead Sciences (GILD): 'We Are Excited By Gilead's Recent String Of Deals'

April 8, 2026 9:02 AM
TD Cowen analyst Tyler Van Buren reiterated a Buy rating and $160.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments